NEW YORK, Feb 13 – Ariad Pharmaceuticals received a patent for a method to control gene expression in humans and other animals, the company said Tuesday.

The technology uses small molecules to regulate the extent of gene activation. It is part of Ariad’s Argent gene regulation system, a gene regulation technology designed for high throughput analysis of in vitro and in vivo gene function, and " dose-dependent control” of gene and cell therapy products, Ariad said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.

Futurism writes that gene doping could be the next generation of cheating in sports.